Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.785
+0.155 (3.35%)
Feb 5, 2025, 2:49 PM EST - Market open
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $800.93 million as of February 5, 2025. Its market cap has decreased by -38.27% in one year.
Market Cap
800.93M
Enterprise Value
18.67M
1-Year Change
-38.27%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $800.93M, a decrease of -73.61%. That is a compound annual growth rate of -25.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 774.98M | 12.38% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.82B |
| UnitedHealth Group | 501.97B |
| Johnson & Johnson | 369.55B |
| Novo Nordisk | 366.04B |
| AbbVie | 335.67B |
| Merck & Co. | 229.54B |
| Abbott Laboratories | 223.92B |
| Thermo Fisher Scientific | 222.07B |